Rocket Pharmaceuticals (RCKT) Tops Q1 EPS by 3c
Tweet
Share
E-mail
Get Alerts RCKT Hot Sheet
Join SI Premium – FREE
Rocket Pharmaceuticals (NASDAQ: RCKT) reported Q1 EPS of ($0.56), $0.03 better than the analyst estimate of ($0.59).
For earnings history and earnings-related data on Rocket Pharmaceuticals (RCKT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Canaccord Downgrades Mayne Pharma Group Ltd. (MYX:AU) (MAYNF) to Spec. Buy
- UBS Upgrades Watches of Switzerland (WOSG:LN) to Buy
- Faraday Future displays robotics lineup at ISTE Live 2026
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
